Novo Nordisk A/S ADR buy The Goldman Sachs Group, Inc.
Start price
28.11.25
/
50%
€42.70
Target price
28.11.26
€46.61
Performance (%)
-2.22%
Price
18.02.26
€41.75
Summary
This prediction is currently active. With a performance of -2.22%, the BUY prediction for Novo Nordisk A/S ADR by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 28.11.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 1.705% | 1.705% |
| iShares Core DAX® | 1.066% | -0.525% |
| iShares Nasdaq 100 | -0.493% | -4.055% |
| iShares Nikkei 225® | -2.028% | 6.911% |
| iShares S&P 500 | -0.103% | -2.366% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $60.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€123.00
30.05.24
30.05.24
€144.02
30.05.25
30.05.25
-49.11%
31.05.25
31.05.25
